牙周治疗与TNF-α抑制剂对共病牙周炎和银屑病协同治疗作用的实验研究
该研究在56只C57/BL6J小鼠中建立结扎诱导牙周炎与咪喹莫特诱导银屑病共病模型,随机分为7组,评估牙周治疗对银屑病结局的辅助作用及TNF-α抑制剂对牙周组织的影响。结果显示,在共病组中,牙周治疗联合TNF-α抑制剂可显著减轻背部皮肤表皮增厚和炎症浸润,并降低牙槽骨丧失及循环IL-6、IL-17A水平。
要点
- 在共病模型中,牙周治疗对TNF-α抑制剂减轻表皮增厚和炎症浸润有显著辅助作用(p<0.05)。
- TNF-α抑制剂对牙周治疗减少牙槽骨丧失有显著辅助作用(p<0.05)。
- 联合治疗可显著降低循环IL-6和IL-17A水平。
核心结论
- 牙周治疗与TNF-α抑制剂联合在实验性结扎诱导牙周炎和IMQ诱导银屑病共病中通过降低全身炎症表现出正向协同作用。
研究设计与样本
- 研究为动物实验,56只C57/BL6J小鼠随机分为7组:对照组(P-Pso-)无治疗;牙周炎组(P+Pso-)接受牙周治疗;牙周炎组(P+Pso-)接受TNF-α抑制剂;银屑病组(P-Pso+)接受TNF-α抑制剂;牙周炎合并银屑病组(P+Pso+)接受牙周治疗;P+Pso+组接受TNF-α抑制剂;P+Pso+组同时接受牙周治疗和TNF-α抑制剂。
主要发现
- 在P+Pso+组中,牙周治疗对TNF-α抑制剂在减少背部皮肤表皮增厚和炎症浸润方面有显著辅助作用(p<0.05)。
- TNF-α抑制剂对牙周治疗在减少牙槽骨丧失方面有显著辅助作用(p<0.05)。
- 同时给予牙周治疗和TNF-α抑制剂时,循环IL-6和IL-17A水平显著降低。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIM: To assess the adjunctive effect of periodontal therapy on psoriasis-related outcomes in a combined experimental model of ligature-induced periodontitis and Imiquimod (IMQ)-induced psoriasis. Also, this experiment aimed to study the impact of TNF-α inhibitors on the periodontium. METHODS: Fifty-six C57/BL6J mice were randomly allocated to seven experimental groups: (a) control group (P-Pso-) with no treatment; (b) periodontitis (P+Pso-) with periodontal therapy; (c) periodontitis (P+Pso-) with TNF-α inhibitor; (d) psoriasis (P-Pso+) with TNF-α inhibitor; (e) periodontitis and psoriasis (P+Pso+) with periodontal therapy; (f) P+Pso+ with TNF-α inhibitor; and (g) P+Pso+ with both periodontal therapy and TNF-α inhibitor. Samples (maxilla, dorsal skin and blood) were harvested immediately after death. Measures of periodontitis distance between the cemento-enamel junction and alveolar bone crest (CEJ-ABC) and number of osteoclasts and psoriasis (epidermal thickness and infiltrate cells (per 0.03mm2)) severity, as well as systemic inflammation (IL-6, IL-17A and TNF-α) were collected. RESULTS: In the P+Pso+ group, a significant adjunctive effect of periodontal therapy to TNF-α inhibitors was found in the reduction of epidermal thickening and inflammatory infiltrate of the dorsal skin (p < 0.05). Similarly, treatment with TNF-α inhibitor resulted in a significant adjunctive effect to periodontal therapy in the reduction of alveolar bone loss (p < 0.05). These changes were accompanied by a significant decrease in the circulating levels of IL-6 and IL-17A when both periodontal therapy and TNF-α inhibitor were administered. CONCLUSIONS: The combination of periodontal therapy and TNF-α inhibitor showed a positive synergetic effect in the treatment of comorbid experimental ligature-induced periodontitis and IMQ-induced psoriasis via the reduction of systemic inflammation.
引用
- Marruganti C, Gaeta C, Falciani C, et al. The Synergetic Effect of Periodontal Therapy and TNF-α Inhibitor for the Treatment of Comorbid Periodontitis and Psoriasis. J Clin Periodontol. 2025. PMID: 40277096. doi:10.1111/jcpe.14102
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。